Flu, RSV, COVID-19, and other respiratory illness updates, risks, and prevention advice.
Sewage may not be glamorous, but it’s become one of the country’s most useful early warning systems for COVID-19, flu, and RSV. Here’s how CDC’s wastewater surveillance works—and how families should interpret rising or falling trends.
CDC’s unified Respiratory Virus Guidance replaces fixed COVID-19 isolation timelines with a symptom-based approach. Here’s what “stay home until symptoms are improving and fever-free for 24 hours” really means for families, schools, and workplaces in 2026.
CDC data show ongoing national activity for COVID-19, influenza, and RSV as winter 2026 winds down. Here’s what primary care clinicians want families to understand about symptoms, testing, antivirals, vaccines, and when to seek care.
A plain-language guide to the CDC’s 2025–2026 recommendations for COVID-19, flu, and RSV vaccines—who should get them, when to schedule them, whether you can get them together, and what most Americans will pay (often $0).
CDC’s 2025–2026 recommendations for influenza, COVID-19, and RSV vaccination clarify who should be vaccinated, when doses should be given, and how coverage works under Medicare and private insurance. Here’s what patients and physicians need to know this season.
If you’re 32–36 weeks pregnant during RSV season, a one-time RSV vaccine may help protect your newborn during the highest-risk months. Here’s how it works, how it compares with infant nirsevimab, what the trial data show, and what to consider for the 2025–2026 season.
The CDC’s interim 2025–2026 flu vaccine effectiveness estimates show moderate protection against medically attended influenza this season. Here’s what the numbers mean, how they’re calculated, and why vaccination and early treatment still matter.
The CDC has released its 2025–2026 COVID-19 vaccine recommendations following FDA authorization of an updated strain formulation. Here’s who should get the new shot, what evidence supports it, how it works with flu and RSV vaccines, and what it means for cost and access in the United States.
A practical, evidence-based checklist for U.S. households to prepare for respiratory virus season and disasters that interrupt care, based on CDC and federal emergency guidance.
If you have asthma, federal health officials consider you at higher risk for complications from flu and COVID-19, and some groups face higher RSV risk. Here’s what the 2025–2026 respiratory virus season means for vaccines, action plans, and when to seek care.
CDC and ACIP have updated guidance for COVID-19, flu, and RSV vaccines for the 2025–2026 respiratory season. Here’s who should get vaccinated, whether shots can be given together, and how Medicare, Medicaid, and private insurance coverage works.
A practical guide for U.S. families on how maternal RSV vaccination during pregnancy and infant nirsevimab are reducing hospitalizations this 2025–2026 respiratory virus season.
For the 2025–2026 flu season, U.S. vaccines protect against three strains instead of four. Here’s why public health experts dropped one influenza B lineage — and what that means for your family’s protection this year.
Flu activity remains elevated across much of the United States in mid-March 2026. Here’s what that means for families, older adults, and people with chronic conditions—and the practical steps that still make a difference.
RSV remains a leading cause of hospitalization in U.S. infants, but maternal vaccination and infant immunization are reshaping protection in the 2025–2026 season. Here’s what families should know.
RSV is not just a childhood virus. Updated 2026 CDC guidance clarifies which older adults should receive an RSV vaccine, who is at highest risk, and how one dose can reduce the chance of severe lung infection and hospitalization.
H5 bird flu continues to affect U.S. poultry and dairy herds, with a limited number of human cases linked to animal exposure. Here’s what the CDC says about current risk, symptoms to watch for, and why experts remain focused on preventing person-to-person spread.
For the 2025–2026 flu season, U.S. flu vaccines have shifted from quadrivalent to trivalent formulas. Here’s what changed, why health officials made the move, and what it means for your protection this year.
Flu activity has remained elevated across much of the United States this season. Here’s what that means for families, older adults, and people at higher risk—and what to do now.
Respiratory viruses remain a steady pressure on hospitals across the United States. Here’s how healthcare systems are adapting, what public health guidance says, and what it means for patients and families.
Rapid home tests for COVID-19 and flu are widely available in the United States. Here’s what federal guidance says about how they work, how accurate they are, and when you should follow up with a clinician.
COVID-19, flu, and RSV continue to pose serious risks in nursing homes and long-term care facilities. Here’s what current CDC and CMS guidance means for residents, families, and caregivers in 2026.
End of content
End of content